Transdermal peptide delivery using electroporation.
Potts
R O
RO
Cygnus, Inc., Redwood City, California 94063, USA.
Bommannan
D
D
Wong
O
O
Tamada
J A
JA
Riviere
J E
JE
Monteiro-Riviere
N A
NA
D000279:Administration, Cutaneous; D000818:Animals; D001692:Biological Transport; D002116:Calcitonin / Q000008:administration & dosage; D018274:Electroporation / Q000009:adverse effects; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage; D007328:Insulin / Q000008:administration & dosage; D008051:Lipid Bilayers / Q000737:chemistry; D009496:Neurotensin / Q000008:administration & dosage; D010455:Peptides / Q000008:administration & dosage*; D012867:Skin / Q000378:metabolism; D013552:Swine; D014667:Vasopressins / Q000008:administration & dosage
D007328:Insulin; D008051:Lipid Bilayers; D010455:Peptides; D014667:Vasopressins; D007987:Gonadotropin-Releasing Hormone; D009496:Neurotensin; D002116:Calcitonin